ESC 365 - Targeting RNA for treatment of dyslipidaemias.

ESC Professional Premium Access

Targeting RNA for treatment of dyslipidaemias.

Session: Emerging role of RNAs as treatment targets in cardiovascular disease

Topic: Cardiovascular Pharmacotherapy

Speaker: Professor S. Tsimikas (La Jolla, US)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Professor Sotirios Tsimikas

University of California San Diego, La Jolla (United States of America)

6 presentations

1 follower

3 more presentations in this session

Targeting RNA to reverse pathological cardiac hypertrophy.

Speaker: Professor T. Thum (Hannover, DE)

Targeting RNA to facilitate cardiac remodelling and to treat heart failure.

Speaker: Mrs P. da Costa Martins (Maastricht, NL)

Emerging role of RNAs as treatment targets in cardiovascular disease – discussion.

Access the full session

Emerging role of RNAs as treatment targets in cardiovascular disease

Speakers: Professor S. Tsimikas, Professor T. Thum, Mrs P. da Costa Martins

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources